Cofinimmo (COFB) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
25 Jul, 2025Executive summary
Net result from core activities (EPRA Earnings) rose 2.4–2.5% to €122 million, exceeding outlook; net result group share at €112 million, up €70 million year-over-year.
Gross rental income reached €177 million, up nearly 3% like-for-like; occupancy rate at 98.6% and average lease term of 13 years.
Healthcare real estate now represents 77% of the €6B–€6.4B portfolio, with continued asset rotation and divestments.
Asset rotation plan progressing, with €56 million divested by mid-year, 56%–70% of 2025 target achieved.
Sustainability achievements recognized, including BREEAM certifications, improved climate rankings, and extended ISO 14001 certification.
Financial highlights
EPRA EPS reached €3.19; IFRS net result at €112 million or €2.95 per share, up €70 million year-over-year.
Debt-to-assets ratio at 44.4% as of June 30, expected to be around 43% by year-end; average cost of debt stable at 1.4%.
EPRA LTV at 43.7%; EPRA cost ratio (incl. direct vacancy) at 18.5%.
IFRS NAV per share at €89.55, down from €92.84 at year-end 2024.
Like-for-like rental growth of 2.8%–2.9% year-over-year.
Outlook and guidance
EPRA EPS target for 2025 confirmed at minimum €6.20 per share, excluding nonrecurring effects from the Aedifica combination.
Gross dividend outlook for 2025 (payable in 2026) set at €5.20 per share.
Debt-to-assets ratio expected to remain stable at ~43% by year-end.
Net investment budget for 2025: €170 million gross investments, €100 million divestments.
No change in guidance despite being ahead of budget; management maintains a cautious approach.
Latest events from Cofinimmo
- 2025 outperformed outlook with robust healthcare focus, high occupancy, and low debt ratio.COFB
Q4 202520 Feb 2026 - Healthcare assets drive 4% earnings growth and 2024 guidance confirmation.COFB
Q2 20242 Feb 2026 - 2024 results beat expectations with a healthcare-focused portfolio and strong financials.COFB
Q4 202416 Dec 2025 - Core earnings up 2% to €186M, 98.6% occupancy, 2025 EPS ≥€6.20/share confirmed.COFB
Q3 202524 Oct 2025 - Q3 2024 results show robust growth, high occupancy, and strong guidance for EPS and dividend.COFB
Q3 202413 Jun 2025 - Core earnings up 5% in Q1 2025, driven by healthcare and strong occupancy.COFB
Q1 20256 Jun 2025